أعرض في EDS

HSD20 Real-World Treatment Patterns and Outcomes After Introduction of Immune Checkpoint Inhibitors (ICIs) in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (aNSCLC) in Europe (EU4+UK)

التفاصيل البيبلوغرافية
العنوان: HSD20 Real-World Treatment Patterns and Outcomes After Introduction of Immune Checkpoint Inhibitors (ICIs) in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (aNSCLC) in Europe (EU4+UK)
المؤلفون: A Slowley, L Kalilani, J Multani, V Casey, S Mpima, M Yasuda, CC Chen, F Manuguid, J Chao, A Aziez, K Bell, A Stojadinovic
المصدر: Value in Health. 25:S277
بيانات النشر: Elsevier BV, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health
تدمد: 1098-3015
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a2591ac867d5e07893080b7ee31b6a2f
https://doi.org/10.1016/j.jval.2022.09.1364
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........a2591ac867d5e07893080b7ee31b6a2f
قاعدة البيانات: OpenAIRE
الوصف
تدمد:10983015